BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vega D, Acosta FJ, Saavedra P. Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study. World J Psychiatr 2020; 10(11): 260-271 [PMID: 33269222 DOI: 10.5498/wjp.v10.i11.260]
URL: https://www.wjgnet.com/2220-3206/full/v10/i11/260.htm
Number Citing Articles
1
Types of Medication Non-adherence & Approaches to Enhance Medication Adherence in Mental Health Disorders: A Narrative ReviewIndian Journal of Psychological Medicine 2024;  doi: 10.1177/02537176241233745
2
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci, Silvana Galderisi. Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literatureFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.970210
3
Carlos A. Cassiani-Miranda, César A. Arango-Dávila, Jeffrey González-Giraldo, Mario D. Parra-Vera, Jorge Tellez-Vargas, Lilian Rocío Morales-Puerto. Consenso colombiano del tratamiento con cannabidiol (CBD) puro en psiquiatríaRevista Colombiana de Psiquiatría 2023;  doi: 10.1016/j.rcp.2022.10.007
4
Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xie. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use DisorderSchizophrenia Bulletin 2024;  doi: 10.1093/schbul/sbae097
5
Dulcinea Vega, Francisco J. Acosta, Pedro Saavedra, Guillermo Pírez. No adherencia en pacientes con esquizofrenia y trastorno esquizoafectivo. Estudio prospectivo de variables asociadas y posibles subtiposPsiquiatría Biológica 2024; 31(2): 100466 doi: 10.1016/j.psiq.2024.100466